カテゴリー： QYResearch, 世界

世界の肝不全治療薬市場 2019年

【英語タイトル】Global Liver Failure Therapeutics Market Professional Survey Report 2019

QYResearchが出版した調査資料（DATA909X10684）・商品コード：DATA909X10684
・発行会社（調査会社）：QYResearch
・発行日：2019年11月20日（※2024年版があります。お問い合わせください）
・ページ数：113
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後3営業日）
・調査対象地域：グローバル
・産業分野：医薬品・ヘルスケア
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,500 ⇒換算￥518,000見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）USD5,250 ⇒換算￥777,000見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）USD7,000 ⇒換算￥1,036,000見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・郵送（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
※本調査レポートは、肝不全治療薬の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、オルニチンフェニルアセテート、MTL-CEBPA、F-573、BL-1220、PP-100、その他に、用途別には、クリニック、病院、その他にセグメント区分し、肝不全治療薬の世界市場を分析しました。


・エグゼクティブ・サマリー
・肝不全治療薬の世界市場概要
・肝不全治療薬の製造コスト構成分析
・肝不全治療薬の開発・製造工場分析
・主要メーカーの主な指標（生産能力、売上、価格分析）
・肝不全治療薬の地域別分析（生産、売上、主要メーカー、輸出・輸入）
（北米、ヨーロッパ、中国、日本国内、東南アジア、インド）
・肝不全治療薬のセグメント分析（種類別）
（オルニチンフェニルアセテート、MTL-CEBPA、F-573、BL-1220、PP-100、その他）
・肝不全治療薬のセグメント分析（用途別）
（クリニック、病院、その他）
・肝不全治療薬の主要メーカー別分析（生産拠点、製品概要、生産・売上実績）
（Alfact Innovation、BioLineRx Ltd、Cell2B Advanced Therapeutics SA、Conatus Pharmaceuticals Inc、Immune Pharmaceuticals Inc、Mina Therapeutics Ltd、Mylan NV、Ocera Therapeutics Inc、PledPharma AB、Promethera Biosciences SA、Silence Therapeutics Plc、Unicyte AG、Ventria Bioscience、Vital Therapies Inc、）
・肝不全治療薬の市場規模予測（2019年～2025年）
（北米、ヨーロッパ、中国、日本国内、東南アジア、インド）
・マーケティングチャネル・流通業者・顧客
・市場ダイナミクス（市場動向、機会、成長要因、課題、影響因子）
...
【レポートの概要】

The global Liver Failure Therapeutics market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025.
This report focuses on Liver Failure Therapeutics volume and value at global level, regional level and company level. From a global perspective, this report represents overall Liver Failure Therapeutics market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Liver Failure Therapeutics in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Liver Failure Therapeutics manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:
Alfact Innovation
BioLineRx Ltd
Cell2B Advanced Therapeutics SA
Conatus Pharmaceuticals Inc
Immune Pharmaceuticals Inc
Mina Therapeutics Ltd
Mylan NV
Ocera Therapeutics Inc
PledPharma AB
Promethera Biosciences SA
Silence Therapeutics Plc
Unicyte AG
Ventria Bioscience
Vital Therapies Inc

Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India

Segment by Type
Ornithine Phenylacetate
MTL-CEBPA
F-573
BL-1220
PP-100
Others

Segment by Application
Clinic
Hospital
Others

【レポートの目次】

Table of Contents

Executive Summary
1 Industry Overview of Liver Failure Therapeutics
1.1 Definition of Liver Failure Therapeutics
1.2 Liver Failure Therapeutics Segment by Type
1.2.1 Global Liver Failure Therapeutics Production Growth Rate Comparison by Types (2014-2025)
1.2.2 Ornithine Phenylacetate
1.2.3 MTL-CEBPA
1.2.4 F-573
1.2.5 BL-1220
1.2.6 PP-100
1.2.7 Others
1.3 Liver Failure Therapeutics Segment by Applications
1.3.1 Global Liver Failure Therapeutics Consumption Comparison by Applications (2014-2025)
1.3.2 Clinic
1.3.3 Hospital
1.3.4 Others
1.4 Global Liver Failure Therapeutics Overall Market
1.4.1 Global Liver Failure Therapeutics Revenue (2014-2025)
1.4.2 Global Liver Failure Therapeutics Production (2014-2025)
1.4.3 North America Liver Failure Therapeutics Status and Prospect (2014-2025)
1.4.4 Europe Liver Failure Therapeutics Status and Prospect (2014-2025)
1.4.5 China Liver Failure Therapeutics Status and Prospect (2014-2025)
1.4.6 Japan Liver Failure Therapeutics Status and Prospect (2014-2025)
1.4.7 Southeast Asia Liver Failure Therapeutics Status and Prospect (2014-2025)
1.4.8 India Liver Failure Therapeutics Status and Prospect (2014-2025)

2 Manufacturing Cost Structure Analysis
2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Liver Failure Therapeutics
2.3 Manufacturing Process Analysis of Liver Failure Therapeutics
2.4 Industry Chain Structure of Liver Failure Therapeutics

3 Development and Manufacturing Plants Analysis of Liver Failure Therapeutics
3.1 Capacity and Commercial Production Date
3.2 Global Liver Failure Therapeutics Manufacturing Plants Distribution
3.3 Major Manufacturers Technology Source and Market Position of Liver Failure Therapeutics
3.4 Recent Development and Expansion Plans

4 Key Figures of Major Manufacturers
4.1 Liver Failure Therapeutics Production and Capacity Analysis
4.2 Liver Failure Therapeutics Revenue Analysis
4.3 Liver Failure Therapeutics Price Analysis
4.4 Market Concentration Degree

5 Liver Failure Therapeutics Regional Market Analysis
5.1 Liver Failure Therapeutics Production by Regions
5.1.1 Global Liver Failure Therapeutics Production by Regions
5.1.2 Global Liver Failure Therapeutics Revenue by Regions
5.2 Liver Failure Therapeutics Consumption by Regions
5.3 North America Liver Failure Therapeutics Market Analysis
5.3.1 North America Liver Failure Therapeutics Production
5.3.2 North America Liver Failure Therapeutics Revenue
5.3.3 Key Manufacturers in North America
5.3.4 North America Liver Failure Therapeutics Import and Export
5.4 Europe Liver Failure Therapeutics Market Analysis
5.4.1 Europe Liver Failure Therapeutics Production
5.4.2 Europe Liver Failure Therapeutics Revenue
5.4.3 Key Manufacturers in Europe
5.4.4 Europe Liver Failure Therapeutics Import and Export
5.5 China Liver Failure Therapeutics Market Analysis
5.5.1 China Liver Failure Therapeutics Production
5.5.2 China Liver Failure Therapeutics Revenue
5.5.3 Key Manufacturers in China
5.5.4 China Liver Failure Therapeutics Import and Export
5.6 Japan Liver Failure Therapeutics Market Analysis
5.6.1 Japan Liver Failure Therapeutics Production
5.6.2 Japan Liver Failure Therapeutics Revenue
5.6.3 Key Manufacturers in Japan
5.6.4 Japan Liver Failure Therapeutics Import and Export
5.7 Southeast Asia Liver Failure Therapeutics Market Analysis
5.7.1 Southeast Asia Liver Failure Therapeutics Production
5.7.2 Southeast Asia Liver Failure Therapeutics Revenue
5.7.3 Key Manufacturers in Southeast Asia
5.7.4 Southeast Asia Liver Failure Therapeutics Import and Export
5.8 India Liver Failure Therapeutics Market Analysis
5.8.1 India Liver Failure Therapeutics Production
5.8.2 India Liver Failure Therapeutics Revenue
5.8.3 Key Manufacturers in India
5.8.4 India Liver Failure Therapeutics Import and Export

6 Liver Failure Therapeutics Segment Market Analysis (by Type)
6.1 Global Liver Failure Therapeutics Production by Type
6.2 Global Liver Failure Therapeutics Revenue by Type
6.3 Liver Failure Therapeutics Price by Type

7 Liver Failure Therapeutics Segment Market Analysis (by Application)
7.1 Global Liver Failure Therapeutics Consumption by Application
7.2 Global Liver Failure Therapeutics Consumption Market Share by Application (2014-2019)

8 Liver Failure Therapeutics Major Manufacturers Analysis
8.1 Alfact Innovation
8.1.1 Alfact Innovation Liver Failure Therapeutics Production Sites and Area Served
8.1.2 Alfact Innovation Product Introduction, Application and Specification
8.1.3 Alfact Innovation Liver Failure Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.1.4 Main Business and Markets Served
8.2 BioLineRx Ltd
8.2.1 BioLineRx Ltd Liver Failure Therapeutics Production Sites and Area Served
8.2.2 BioLineRx Ltd Product Introduction, Application and Specification
8.2.3 BioLineRx Ltd Liver Failure Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.2.4 Main Business and Markets Served
8.3 Cell2B Advanced Therapeutics SA
8.3.1 Cell2B Advanced Therapeutics SA Liver Failure Therapeutics Production Sites and Area Served
8.3.2 Cell2B Advanced Therapeutics SA Product Introduction, Application and Specification
8.3.3 Cell2B Advanced Therapeutics SA Liver Failure Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.3.4 Main Business and Markets Served
8.4 Conatus Pharmaceuticals Inc
8.4.1 Conatus Pharmaceuticals Inc Liver Failure Therapeutics Production Sites and Area Served
8.4.2 Conatus Pharmaceuticals Inc Product Introduction, Application and Specification
8.4.3 Conatus Pharmaceuticals Inc Liver Failure Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.4.4 Main Business and Markets Served
8.5 Immune Pharmaceuticals Inc
8.5.1 Immune Pharmaceuticals Inc Liver Failure Therapeutics Production Sites and Area Served
8.5.2 Immune Pharmaceuticals Inc Product Introduction, Application and Specification
8.5.3 Immune Pharmaceuticals Inc Liver Failure Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.5.4 Main Business and Markets Served
8.6 Mina Therapeutics Ltd
8.6.1 Mina Therapeutics Ltd Liver Failure Therapeutics Production Sites and Area Served
8.6.2 Mina Therapeutics Ltd Product Introduction, Application and Specification
8.6.3 Mina Therapeutics Ltd Liver Failure Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.6.4 Main Business and Markets Served
8.7 Mylan NV
8.7.1 Mylan NV Liver Failure Therapeutics Production Sites and Area Served
8.7.2 Mylan NV Product Introduction, Application and Specification
8.7.3 Mylan NV Liver Failure Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.7.4 Main Business and Markets Served
8.8 Ocera Therapeutics Inc
8.8.1 Ocera Therapeutics Inc Liver Failure Therapeutics Production Sites and Area Served
8.8.2 Ocera Therapeutics Inc Product Introduction, Application and Specification
8.8.3 Ocera Therapeutics Inc Liver Failure Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.8.4 Main Business and Markets Served
8.9 PledPharma AB
8.9.1 PledPharma AB Liver Failure Therapeutics Production Sites and Area Served
8.9.2 PledPharma AB Product Introduction, Application and Specification
8.9.3 PledPharma AB Liver Failure Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.9.4 Main Business and Markets Served
8.10 Promethera Biosciences SA
8.10.1 Promethera Biosciences SA Liver Failure Therapeutics Production Sites and Area Served
8.10.2 Promethera Biosciences SA Product Introduction, Application and Specification
8.10.3 Promethera Biosciences SA Liver Failure Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.10.4 Main Business and Markets Served
8.11 Silence Therapeutics Plc
8.12 Unicyte AG
8.13 Ventria Bioscience
8.14 Vital Therapies Inc

9 Development Trend of Analysis of Liver Failure Therapeutics Market
9.1 Global Liver Failure Therapeutics Market Trend Analysis
9.1.1 Global Liver Failure Therapeutics Market Size (Volume and Value) Forecast 2019-2025
9.2 Liver Failure Therapeutics Regional Market Trend
9.2.1 North America Liver Failure Therapeutics Forecast 2019-2025
9.2.2 Europe Liver Failure Therapeutics Forecast 2019-2025
9.2.3 China Liver Failure Therapeutics Forecast 2019-2025
9.2.4 Japan Liver Failure Therapeutics Forecast 2019-2025
9.2.5 Southeast Asia Liver Failure Therapeutics Forecast 2019-2025
9.2.6 India Liver Failure Therapeutics Forecast 2019-2025
9.3 Liver Failure Therapeutics Market Trend (Product Type)
9.4 Liver Failure Therapeutics Market Trend (Application)

10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.3 Liver Failure Therapeutics Customers

11 Market Dynamics
11.1 Market Trends
11.2 Opportunities
11.3 Market Drivers
11.4 Challenges
11.5 Influence Factors

12 Conclusion
13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Author List
13.4 Disclaimer

List of Tables and Figures
Figure Picture of Liver Failure Therapeutics
Table Global Liver Failure Therapeutics Production (K Pcs) Growth Rate Comparison by Types (2014-2025)
Figure Global Liver Failure Therapeutics Production Market Share by Types in 2018
Figure Ornithine Phenylacetate Product Picture
Figure MTL-CEBPA Product Picture
Figure F-573 Product Picture
Figure BL-1220 Product Picture
Figure PP-100 Product Picture
Figure Others Product Picture
Table Global Liver Failure Therapeutics Consumption (K Pcs) Comparison by Applications (2014-2025)
Figure Global Liver Failure Therapeutics Consumption Market Share by Applications in 2018
Figure Clinic
Figure Hospital
Figure Others
Figure Global Liver Failure Therapeutics Revenue (Million USD) (2014-2025)
Figure Global Liver Failure Therapeutics Production (K Pcs) (2014-2025)
Figure North America Liver Failure Therapeutics Market Size (Million USD) (2014-2025)
Figure Europe Liver Failure Therapeutics Market Size (Million USD) (2014-2025)
Figure China Liver Failure Therapeutics Market Size (Million USD) (2014-2025)
Figure Japan Liver Failure Therapeutics Market Size (Million USD) (2014-2025)
Figure Southeast Asia Liver Failure Therapeutics Market Size (Million USD) (2014-2025)
Figure India Liver Failure Therapeutics Market Size (Million USD) (2014-2025)
Table Liver Failure Therapeutics Raw Material and Suppliers
Table Manufacturing Cost Structure Analysis of Liver Failure Therapeutics in 2018
Figure Manufacturing Process Analysis of Liver Failure Therapeutics
Figure Industry Chain Structure of Liver Failure Therapeutics
Table Capacity and Commercial Production Date of Key Manufacturers
Table Global Liver Failure Therapeutics Manufacturing Plants Distribution
Table Liver Failure Therapeutics Major Manufacturers Technology Source and Market Position
Table Recent Development and Expansion Plans in Future
Table Liver Failure Therapeutics Capacity (K Pcs) of Major Manufacturers (2014-2019)
Table Liver Failure Therapeutics Production (K Pcs) of Major Manufacturers (2014-2019)
Table Liver Failure Therapeutics Production Market Share of Major Manufacturers (2014-2019)
Figure Liver Failure Therapeutics Production Share by Manufacturers in 2018
Table Liver Failure Therapeutics Revenue (Million US$) of Major Manufacturers (2014-2019)
Table Liver Failure Therapeutics Revenue Market Share of Major Manufacturers (2014-2019)
Figure Liver Failure Therapeutics Revenue Share by Manufacturers in 2018
Table Liver Failure Therapeutics Average Price (USD/Pcs) of Major Manufacturers (2014-2019)
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Global Liver Failure Therapeutics Production by Regions 2014-2019 (K Pcs)
Table Global Liver Failure Therapeutics Production Market Share by Regions 2014-2019
Figure Global Liver Failure Therapeutics Production Market Share by Regions in 2018
Table Global Liver Failure Therapeutics Revenue by Regions 2014-2019 (Million USD)
Table Global Liver Failure Therapeutics Revenue Market Share by Regions 2014-2019
Figure Global Liver Failure Therapeutics Revenue Market Share by Regions in 2018
Table Global Liver Failure Therapeutics Consumption by Regions 2014-2019 (K Pcs)
Table Global Liver Failure Therapeutics Consumption Market Share by Regions 2014-2019
Figure North America Liver Failure Therapeutics Production Growth Rate 2014-2019 (K Pcs)
Figure North America Liver Failure Therapeutics Revenue Growth Rate 2014-2019 (Million USD)
Table North America Liver Failure Therapeutics Production, Consumption Import and Export (K Pcs)
Figure Europe Liver Failure Therapeutics Production Growth Rate 2014-2019 (K Pcs)
Figure Europe Liver Failure Therapeutics Revenue Growth Rate 2014-2019 (Million USD)
Table Europe Liver Failure Therapeutics Production, Consumption Import and Export (K Pcs)
Figure China Liver Failure Therapeutics Production Growth Rate 2014-2019 (K Pcs)
Figure China Liver Failure Therapeutics Revenue Growth Rate 2014-2019 (Million USD)
Table China Liver Failure Therapeutics Production, Consumption Import and Export (K Pcs)
Figure Japan Liver Failure Therapeutics Production Growth Rate 2014-2019 (K Pcs)
Figure Japan Liver Failure Therapeutics Revenue Growth Rate 2014-2019 (Million USD)
Table Japan Liver Failure Therapeutics Production, Consumption Import and Export (K Pcs)
Figure Southeast Asia Liver Failure Therapeutics Production Growth Rate 2014-2019 (K Pcs)
Figure Southeast Asia Liver Failure Therapeutics Revenue Growth Rate 2014-2019 (Million USD)
Table Southeast Asia Liver Failure Therapeutics Production, Consumption Import and Export (K Pcs)
Figure India Liver Failure Therapeutics Production Growth Rate 2014-2019 (K Pcs)
Figure India Liver Failure Therapeutics Revenue Growth Rate 2014-2019 (Million USD)
Table India Liver Failure Therapeutics Production, Consumption Import and Export (K Pcs)
Figure Global Consumption Liver Failure Therapeutics Market Share by Application (2014-2019)
Figure Global Value (Consumption) Liver Failure Therapeutics Market Share by Application (2014-2019)
Table Alfact Innovation Liver Failure Therapeutics Production Sites and Area Served
Table Alfact Innovation Liver Failure Therapeutics Product Introduction, Application and Specification
Table Alfact Innovation Liver Failure Therapeutics Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Alfact Innovation Liver Failure Therapeutics Production Growth Rate (2014-2019)
Table Alfact Innovation Liver Failure Therapeutics Production Market Share (2014-2019)
Figure Alfact Innovation Liver Failure Therapeutics Revenue Market Share (2014-2019)
Table Alfact Innovation Liver Failure Therapeutics Main Business and Markets Served
Table BioLineRx Ltd Liver Failure Therapeutics Production Sites and Area Served
Table BioLineRx Ltd Liver Failure Therapeutics Product Introduction, Application and Specification
Table BioLineRx Ltd Liver Failure Therapeutics Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table BioLineRx Ltd Liver Failure Therapeutics Production Growth Rate (2014-2019)
Table BioLineRx Ltd Liver Failure Therapeutics Production Market Share (2014-2019)
Figure BioLineRx Ltd Liver Failure Therapeutics Revenue Market Share (2014-2019)
Table BioLineRx Ltd Liver Failure Therapeutics Main Business and Markets Served
Table Cell2B Advanced Therapeutics SA Liver Failure Therapeutics Production Sites and Area Served
Table Cell2B Advanced Therapeutics SA Liver Failure Therapeutics Product Introduction, Application and Specification
Table Cell2B Advanced Therapeutics SA Liver Failure Therapeutics Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Cell2B Advanced Therapeutics SA Liver Failure Therapeutics Production Growth Rate (2014-2019)
Table Cell2B Advanced Therapeutics SA Liver Failure Therapeutics Production Market Share (2014-2019)
Figure Cell2B Advanced Therapeutics SA Liver Failure Therapeutics Revenue Market Share (2014-2019)
Table Cell2B Advanced Therapeutics SA Liver Failure Therapeutics Main Business and Markets Served
Table Conatus Pharmaceuticals Inc Liver Failure Therapeutics Production Sites and Area Served
Table Conatus Pharmaceuticals Inc Liver Failure Therapeutics Product Introduction, Application and Specification
Table Conatus Pharmaceuticals Inc Liver Failure Therapeutics Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Conatus Pharmaceuticals Inc Liver Failure Therapeutics Production Growth Rate (2014-2019)
Table Conatus Pharmaceuticals Inc Liver Failure Therapeutics Production Market Share (2014-2019)
Figure Conatus Pharmaceuticals Inc Liver Failure Therapeutics Revenue Market Share (2014-2019)
Table Conatus Pharmaceuticals Inc Liver Failure Therapeutics Main Business and Markets Served
Table Immune Pharmaceuticals Inc Liver Failure Therapeutics Production Sites and Area Served
Table Immune Pharmaceuticals Inc Liver Failure Therapeutics Product Introduction, Application and Specification
Table Immune Pharmaceuticals Inc Liver Failure Therapeutics Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Immune Pharmaceuticals Inc Liver Failure Therapeutics Production Growth Rate (2014-2019)
Table Immune Pharmaceuticals Inc Liver Failure Therapeutics Production Market Share (2014-2019)
Figure Immune Pharmaceuticals Inc Liver Failure Therapeutics Revenue Market Share (2014-2019)
Table Immune Pharmaceuticals Inc Liver Failure Therapeutics Main Business and Markets Served
Table Mina Therapeutics Ltd Liver Failure Therapeutics Production Sites and Area Served
Table Mina Therapeutics Ltd Liver Failure Therapeutics Product Introduction, Application and Specification
Table Mina Therapeutics Ltd Liver Failure Therapeutics Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Mina Therapeutics Ltd Liver Failure Therapeutics Production Growth Rate (2014-2019)
Table Mina Therapeutics Ltd Liver Failure Therapeutics Production Market Share (2014-2019)
Figure Mina Therapeutics Ltd Liver Failure Therapeutics Revenue Market Share (2014-2019)
Table Mina Therapeutics Ltd Liver Failure Therapeutics Main Business and Markets Served
Table Mylan NV Liver Failure Therapeutics Production Sites and Area Served
Table Mylan NV Liver Failure Therapeutics Product Introduction, Application and Specification
Table Mylan NV Liver Failure Therapeutics Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Mylan NV Liver Failure Therapeutics Production Growth Rate (2014-2019)
Table Mylan NV Liver Failure Therapeutics Production Market Share (2014-2019)
Figure Mylan NV Liver Failure Therapeutics Revenue Market Share (2014-2019)
Table Mylan NV Liver Failure Therapeutics Main Business and Markets Served
Table Ocera Therapeutics Inc Liver Failure Therapeutics Production Sites and Area Served
Table Ocera Therapeutics Inc Liver Failure Therapeutics Product Introduction, Application and Specification
Table Ocera Therapeutics Inc Liver Failure Therapeutics Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Ocera Therapeutics Inc Liver Failure Therapeutics Production Growth Rate (2014-2019)
Table Ocera Therapeutics Inc Liver Failure Therapeutics Production Market Share (2014-2019)
Figure Ocera Therapeutics Inc Liver Failure Therapeutics Revenue Market Share (2014-2019)
Table Ocera Therapeutics Inc Liver Failure Therapeutics Main Business and Markets Served
Table PledPharma AB Liver Failure Therapeutics Production Sites and Area Served
Table PledPharma AB Liver Failure Therapeutics Product Introduction, Application and Specification
Table PledPharma AB Liver Failure Therapeutics Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table PledPharma AB Liver Failure Therapeutics Production Growth Rate (2014-2019)
Table PledPharma AB Liver Failure Therapeutics Production Market Share (2014-2019)
Figure PledPharma AB Liver Failure Therapeutics Revenue Market Share (2014-2019)
Table PledPharma AB Liver Failure Therapeutics Main Business and Markets Served
Table Promethera Biosciences SA Liver Failure Therapeutics Production Sites and Area Served
Table Promethera Biosciences SA Liver Failure Therapeutics Product Introduction, Application and Specification
Table Promethera Biosciences SA Liver Failure Therapeutics Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Promethera Biosciences SA Liver Failure Therapeutics Production Growth Rate (2014-2019)
Table Promethera Biosciences SA Liver Failure Therapeutics Production Market Share (2014-2019)
Figure Promethera Biosciences SA Liver Failure Therapeutics Revenue Market Share (2014-2019)
Table Promethera Biosciences SA Liver Failure Therapeutics Main Business and Markets Served
Table Silence Therapeutics Plc Liver Failure Therapeutics Production Sites and Area Served
Table Unicyte AG Liver Failure Therapeutics Production Sites and Area Served
Table Ventria Bioscience Liver Failure Therapeutics Production Sites and Area Served
Table Vital Therapies Inc Liver Failure Therapeutics Production Sites and Area Served
Figure Global Liver Failure Therapeutics Production (K Pcs) Growth Rate Forecast 2019-2025
Figure Global Liver Failure Therapeutics Revenue (Million USD) Growth Rate Forecast 2019-2025
Figure Global Liver Failure Therapeutics Sales Price (USD/Pcs) Forecast 2019-2025
Figure North America Liver Failure Therapeutics Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure North America Liver Failure Therapeutics Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Europe Liver Failure Therapeutics Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure Europe Liver Failure Therapeutics Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure China Liver Failure Therapeutics Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure China Liver Failure Therapeutics Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Japan Liver Failure Therapeutics Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure Japan Liver Failure Therapeutics Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Southeast Asia Liver Failure Therapeutics Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure Southeast Asia Liver Failure Therapeutics Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure India Liver Failure Therapeutics Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure India Liver Failure Therapeutics Revenue Growth Rate Forecast 2019-2025 (Million USD)
Table Global Production (K Pcs) of Liver Failure Therapeutics by Type (2019-2025)
Table Global Consumption (K Pcs) of Liver Failure Therapeutics by Application (2019-2025)
Table Liver Failure Therapeutics Distributors List
Table Liver Failure Therapeutics Customers List
Table Market Key Trends
Table Key Opportunities
Table Market Key Drivers
Table Key Challenges
Table Key Influence Factors
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources


【掲載企業】

Alfact Innovation、BioLineRx Ltd、Cell2B Advanced Therapeutics SA、Conatus Pharmaceuticals Inc、Immune Pharmaceuticals Inc、Mina Therapeutics Ltd、Mylan NV、Ocera Therapeutics Inc、PledPharma AB、Promethera Biosciences SA、Silence Therapeutics Plc、Unicyte AG、Ventria Bioscience、Vital Therapies Inc、

★調査レポート[世界の肝不全治療薬市場 2019年] (コード：DATA909X10684)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の肝不全治療薬市場 2019年]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 世界の急性心不全(AHF)治療薬市場 2019年
    DATA909X02947 / QYResearch / 2019年11月15日 / ※本調査レポートは、急性心不全(AHF)治療薬の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、β遮断薬、カルシウム拮抗薬、強心配糖体、利尿薬、モルヒネ、血管拡張薬/硝酸塩、その他に、用途別には、病院、クリニック、ホームケアにセグメント区分し、急性心不全(AHF)治療薬の世界市場を分析しました。 ・エグゼクティブ・サマリー ・急性心不全(AHF)治療薬の世界市場概要 ・急性心不全(AHF)治療薬の製造コスト構成分析 ・急性心不全(AHF)治療薬の開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・急性心不全(AHF)治療薬の地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・急性心不全(AHF)治療薬のセグメント分析（種類別） （β遮断薬、カルシウム拮抗薬、強心配糖体、利尿薬、モルヒネ、血管拡張薬/硝酸塩、その他）...The global Acute Heart Failure (AHF) Therapeutics market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Acute Heart Failure (AHF) Therapeutics volume and value at global level, regional level and company level. From a global perspective, this report represents overall Acute Heart Failure (AHF) Therapeutics market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Acute Heart Failure (AHF) Therapeutics in North America, Europe, China, Japan, Southeast Asia and...
  • 世界の故障解析機器市場 2019年
    DATA909X07590 / QYResearch / 2019年11月15日 / ※本調査レポートは、故障解析機器の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、SEM、TEM、FIB、デュアルに、用途別には、材料科学、生物科学、産業およびエレクトロニクスにセグメント区分し、故障解析機器の世界市場を分析しました。 ・エグゼクティブ・サマリー ・故障解析機器の世界市場概要 ・故障解析機器の製造コスト構成分析 ・故障解析機器の開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・故障解析機器の地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・故障解析機器のセグメント分析（種類別） （SEM、TEM、FIB、デュアル）...The global Failure Analysis Equipment market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Failure Analysis Equipment volume and value at global level, regional level and company level. From a global perspective, this report represents overall Failure Analysis Equipment market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Failure Analysis Equipment in North America, Europe, China, Japan, Southeast Asia and India. For each manufacturer covered, this report analyzes...
  • 世界のヒト肝臓モデル市場 2019年
    DATA909X09343 / QYResearch / 2019年11月20日 / ※本調査レポートは、ヒト肝臓モデルの世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、肝臓オルガノイド、肝臓オンチップ、2Dモデル、3Dバイオプリンティング、その他に、用途別には、創薬、教育、その他にセグメント区分し、ヒト肝臓モデルの世界市場を分析しました。 ・エグゼクティブ・サマリー ・ヒト肝臓モデルの世界市場概要 ・ヒト肝臓モデルの製造コスト構成分析 ・ヒト肝臓モデルの開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・ヒト肝臓モデルの地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・ヒト肝臓モデルのセグメント分析（種類別） （肝臓オルガノイド、肝臓オンチップ、2Dモデル、3Dバイオプリンティング、その他）...The global Human Liver Model market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Human Liver Model volume and value at global level, regional level and company level. From a global perspective, this report represents overall Human Liver Model market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Human Liver Model in North America, Europe, China, Japan, Southeast Asia and India. For each manufacturer covered, this report analyzes...
  • 世界の肝癌診断検査市場 2019年
    DATA909X10683 / QYResearch / 2019年11月20日 / ※本調査レポートは、肝癌診断検査の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、試薬、計器に、用途別には、病院、身体検査センター、その他にセグメント区分し、肝癌診断検査の世界市場を分析しました。 ・エグゼクティブ・サマリー ・肝癌診断検査の世界市場概要 ・肝癌診断検査の製造コスト構成分析 ・肝癌診断検査の開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・肝癌診断検査の地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・肝癌診断検査のセグメント分析（種類別） （試薬、計器）...The global Liver Cancer Diagnostic Tests market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Liver Cancer Diagnostic Tests volume and value at global level, regional level and company level. From a global perspective, this report represents overall Liver Cancer Diagnostic Tests market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Liver Cancer Diagnostic Tests in North America, Europe, China, Japan, Southeast Asia and India. For each manufacturer...

    • ◆H&Iグローバルリサーチのお客様（例）◆